Impact BioMedical Inc.'s latest marketcap:
As of 07/29/2025, Impact BioMedical Inc.'s market capitalization has reached $5.4 M. According to our data, Impact BioMedical Inc. is the 43524th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 5.4 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -25,013,000 |
| Shares Out | 12.09 M |
| EPS (ttm) | -2.22 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/23/2025 |
Impact BioMedical Inc.'s yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 07/29/2025 | $5.4 M | -49.23% | 43524 |
| 12/31/2024 | $16.68 M | n/a |
Company Profile
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States.
The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone.
It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances.
In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use in as health supplements and medications.
Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas.
Frequently Asked Questions
-
What is Impact BioMedical Inc.'s (IBO) current market cap?As of 07/29/2025, Impact BioMedical Inc. (including the parent company, if applicable) has an estimated market capitalization of $5.4 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Impact BioMedical Inc. (IBO) rank globally by market cap?Impact BioMedical Inc. global market capitalization ranking is approximately 43524 as of 07/29/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.